Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals
AUTOR(ES)
Almeida, Laura Ramos de; Criado, Roberta Fachini; Criado, Paulo Ricardo; Ensina, Luis Felipe; Abdalla, Beatrice Martinez Zugaib; Quaresma, Juarez Antônio Simões
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2021-08
RESUMO
Abstract Background: The ear is a region that has a high prevalence of cutaneous carcinomas and several guidelines indicate Mohs micrographic surgery as the first-choice treatment in such cases. Although the technique allows maximum preservation of healthy tissue, many auricular surgical wounds constitute a challenge due to the peculiar local anatomy, with evident curves and reliefs. Auricular reconstruction should prioritize function before aesthetics, but without leaving the latter aside, since postoperative distortions can have a significant psychological impact. Objective: To describe the authors’ experience in auricular reconstruction after Mohs surgery and to evaluate the most frequently used repair methods. Methods: Retrospective study of consecutive cases submitted to Mohs surgery and auricular reconstruction, over a period of 3 years. Results: One hundred and one cases were included and the most common repair method was primary closure (n = 35), followed by full-thickness skin graft (n = 30) and flaps (n = 24). In thirty cases, reconstruction methods were associated. Seven patients had complications (partial graft necrosis, postoperative bleeding or infection). Study limitations: Retrospective design and the absence of long-term follow-up of some cases. Conclusions: The dermatologic surgeon should be familiarized with different options for auricular reconstruction. Primary closure and skin grafts were the most frequently used repair methods.
Documentos Relacionados
- Incapacitating solar urticaria: successful treatment with omalizumab
- Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
- Chronic urticaria: profile from a reference center
- Responding to unexpected events: Patients have to be treated as individuals
- Infliximab in patients with psoriasis and other inflammatory diseases: evaluation of adverse events in the treatment of 168 patients